David Miller

David W. Miller serves as the CEO and Chair of Genesis Research, a prominent HEOR and market access firm since December 2021, with extensive experience in the life sciences industry. Miller has held multiple board and advisory roles, including serving as a Board Member for ELIQUENT Life Sciences and Envision Pharma Group, and as an Advisory Board Member for Almaden Genomics. As a Venture Partner at Atria Ventures, Miller focuses on sourcing and supporting early-stage tech-bio investments. Previously, Miller was an Operating Partner at GHO Capital Partners and served as Senior Vice President of Global Market Access at Biogen, where significant contributions included overseeing global market access strategies and product launches. Educational credentials include a Bachelor of Science in Pharmacy from the University of Iowa and a PhD in Pharmacy Administration, Health Economics, and Policy from the University of Maryland Baltimore.